Cellect Biotechnology Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced operating income was ILS 22.332 million compared to ILS 29.247 million a year ago. Net loss was ILS 16.808 million compared to ILS 20.113 million a year ago. Basic loss per share was ILS 0.079 compared to ILS 0.155 a year ago.